[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$otskf
FDA rejects Otsuka's PTSD program, while Mizuho and Jefferies offer positive outlooks. Otsuka acquires an autoimmune antibody, sparking mixed reactions.
About $otskf
OTSKF is the stock ticker for Otsuka Pharmaceutical, a pharmaceutical company.
Insights #
- $otskf creators is up XXX% from the previous week.
- $otskf mentions is up XXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXX
1 Month: XXXXX +207%
1-Year High: XXXXX on 2025-07-18
1-Year Low: X on 2025-07-03
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +400%
1 Month: X +200%
1-Year High: X on 2025-07-18
1-Year Low: X on 2025-06-02
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $otskf in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +200%
1 Month: X +200%
1-Year High: X on 2025-07-18
1-Year Low: X on 2025-06-02
Sentiment: undefined% #
Top assets mentioned In the posts about $otskf in the last XX hours
Biogen Inc (BIIB) Vertex Protocol (VRTX) Vertex Protocol (VRTX)
Top topics mentioned In the posts about $otskf in the last XX hours
$axsms, $13bn, $biib, $avxl, $jbios, $vrtx, $jbio, vertex protocol, $4768t, $4578t, $ipxhf, $asglf, $koscf, $smfrf, $mrskf
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Citing lack of evidence FDA panel votes against Otsuka's PTSD programme $OTSKF"
@fwpharma on X 2025-07-19 03:27:17 UTC 55.1K followers, XXX engagements
"Mizuho reiterated $AXSM Outperform-$210: $ALKS $ACAD $OTSKF $AVXL $BIIB "Next Monday AXSM will host an R&D Day to showcase its late-stage CNS pipeline which consists of four assets (AXS-05 AXS-12 AXS-14 and solriamfetol) being developed across eight indications and representing (per management guidance) an incremental peak revenue opp'y of$6-$13bn. From a stock perspective we're not necessarily expecting the event to serve as a significant catalyst but that said as we eagerly await an update on AXS-05/Auvelity in Alzheimer's disease agitation/ADA (easily the company's most important pipeline"
@Quantumup1 on X 2025-07-18 15:23:01 UTC 3519 followers, 1356 engagements
"Otsuka snaps up autoimmune antibody from Swedish biotech $OTSKF"
@fwpharma on X 2025-07-15 21:49:46 UTC 55.1K followers, XXX engagements
"Jefferies🏁 $JBIO Buy-$16 $VRTX $OTSKF Jefferies said in its initiation report: "We like $JBIO's long-acting anti-APRIL (JADE101) in IgAN: 1) our PK work suggests '101 can achieve Q8/12W dosing 2) we think efficacy will be as good as povetacicept w/ pot'l upside on % clinical remission 3) we expect tolerable safety profile w/o increased serious infections 4) we see oppty for disease modifying tx w/ longer dosing interval in IgAN. We model $915M risk-adj. PS for '101 (POS 30%). Co also has $255M cash/cash eq. w/ runway to '27.""
@Quantumup1 on X 2025-07-14 19:06:38 UTC 3517 followers, 1061 engagements